Corporate News 13-Jul-24
USFDA classifies inspection of Cipla's Kurkumbh unit as Voluntary Action Indicated
Cipla announced that the United States Food and Drug Administration (USFDA) has classified the routine current Good Manufacturing Practices (cGMP) inspection of its Kurkumbh manufacturing facility, as Voluntary Action Indicated (VAI).
Previous News
Volumes jump at Campus Activewear Ltd counter
( Hot Pursuit - 10-Jul-25 11:00 )
Cipla to conduct board meeting
( Corporate News - 02-Jul-25 10:19 )
Cipla allots 43,396 equity shares under ESOP
( Corporate News - 27-Jun-25 11:02 )
Cipla Ltd spurts 0.42%, up for fifth straight session
( Hot Pursuit - 11-Jun-25 13:00 )
Cipla announced incorporation of subsidiary - CiplaRna GmbH' in Germany
( Corporate News - 29-May-25 18:50 )
Jay Precision Pharmaceuticals acquires 26% stake in AMPIN Energy C&I Eighteen
( Corporate News - 29-May-25 18:48 )
Cipla
( Results - Analysis 14-May-25 10:22 )
Cipla to convene AGM
( Corporate News - 14-May-25 15:08 )
Cipla registers PAT of Rs 1,222 crore in Q4; EBITDA margin rises to 22.8%
( Hot Pursuit - 13-May-25 15:17 )
Board of Cipla recommends final dividend
( Corporate News - 13-May-25 14:34 )
Board of Cipla recommends special dividend
( Corporate News - 13-May-25 14:34 )
Other Stories
Board of HCL Technologies recommends Interim Dividend
14-Jul-25 17:52
Objectone Information Systems to conduct board meeting
14-Jul-25 17:50
JTEKT India AGM scheduled
14-Jul-25 17:50
Setco Automotive to discuss results
14-Jul-25 17:50
Saurashtra Cement to hold board meeting
14-Jul-25 17:49
John Cockerill India to table results
14-Jul-25 17:49
ATV Projects India to conduct board meeting
14-Jul-25 17:49
Shilchar Technologies schedules AGM
14-Jul-25 17:49
Sun Pharma settles litigation related to LEQSELVI™ with Incyte
14-Jul-25 16:53
Sun Pharmaceutical Industries launches LEQSELVI™ (deuruxolitinib) 8 mg tablets in United States
14-Jul-25 16:48
Back
Top
